NCT00136799View on ClinicalTrials.gov

Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia

PHASE3CompletedINTERVENTIONAL
Enrollment

325

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
Mixed DyslipidemiaHypercholesterolemia
Interventions
DRUG

Fluvastatin

Trial Locations (1)

Unknown

Novartis, Shanghai

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY